Additionally, assessment of apoptosis by flow cytometry (Annexin V+/PI- fraction) also showed that RCC cells treated with BEZ235 had increased apoptosis respective to rapamycin treated cells (Figure 3C). The gene discussed is ANXA5; the disease is renal cell carcinoma.